Triducive specialise in generating “consensus-led evidence” that is published and supports change in healthcare. They combine healthcare sector experience with structured expert consensus methods (including the Delphi Method) and support organisations across commercial, public and charitable sectors.
The Consensus Experts
Delphi Panels & Consensus Research Solutions
Triducive are the consensus experts, generating consensus-led evidence that gets published and supports change.
Structured consensus methods such as Nominal Group Technique (NGT) and the more popular Delphi Method (engaging a Delphi panel) are widely used in healthcare to define standards, understand best practice or to establish policies.
Delphi panels can be used in a systematic, iterative process to generate definitions, build clarity, and establish consensus based on expert opinion. Delphi panels can go up to hundreds, depending on projects’ needs, to ensure representation of a mix of perspectives. Usually involving rounds of anonymous questionnaires with controlled feedback, it is one of the most rapid ways to build new evidence and support advocacy. While the Delphi method itself provides methodological rigour, its effectiveness depends on how well a Delphi panel is recruited and supported.
Triducive combine healthcare sector experience with expertise in delivering structured expert consensus to support decisions and facilitate positive change. We work with KOLs all over the world.
“This now provides a clear focus in an area that has been confused for a long time” Microbiologist
“This will add to the evidence base that will inform future practice” Cardiothoracic Surgeon
“A great support to transform future surgery” Chair, Professional Medical Society
Case Studies
Triducive design, facilitate and deliver consensus studies that get published…
With over 50 Delphi studies published in peer-reviewed journals, our manuscripts provide a strong foundation for educating decision-makers in healthcare, including HCPs, regulatory authorities, payers, and public health organizations.
…and turn consensus results into meaningful action with curated communication campaigns that build advocacy
Through powerful campaigns across a range of audiences, we support positive change at both the national and international levels.
Defining the Clinical Patient Cohort for a New Antibiotic Treatment in a Conservative and Cost-restrictive Market
This Delphi consensus study and related campaign was designed to address:
- Limited clarity from clinicians about when to use the therapy
- Uncertainty from policy-makers about how to position a new high-cost antibiotic treatment
- EU-wide policy to support uptake
PUBLISHED
Journal of hospital infection
JOURNAL IMPACT FACTOR
9
CITATIONS SINCE PUBLICATION
19
Defining Best Practices for Managing Hyperkalaemia in Chronic Kidney Disease (CKD) and Heart Failure (HF) Patients in China
There were variations in clinical practices in China for managing Hyperkalaemia (HK) and the use of renin-angiotensin-aldosterone system inhibitors in patients with Chronic Kidney Disease (CKD) or Heart Failure (HF).
Delphi panels were employed to establish a multi-specialty consensus.
PUBLISHED
Chinese Medical Sciences Journal
JOURNAL IMPACT FACTOR
7.3
CITATIONS SINCE PUBLICATION
2
How we work
Every programme runs end to end under one team: independent facilitators scope the question, design the right approach and carry the findings through to communication.
Structured techniques such as a Delphi panel or the Nominal Group Technique build measured consensus that can be taken through to peer-reviewed publication, while an advisory board provides expert insight and direction. Whichever route fits, we deliver it from the first scoping conversation to final communication.
Wondering if a Delphi consensus study would support your plans? Take our 2-minute test to find out.
Meet the Team
We’re a team with expertise and knowledge across industry, disease areas and healthcare systems. We are based in the UK and deliver work all over the world.
Tim Warren
Managing Partner
Nick Williams
Managing Partner
Rebecca Hornby
Program Director
Emily Lassman
Program Director
Dal Singh
Program Director
Ian Walker
Scientific Director
Lara Zoric
Senior Account Executive
Katie Larner
Content Lead
Guoda Globyte
Senior Account Executive
Hannah Martin
Content Lead
Anna Ribaud
Operations Lead
Katie Williams
Content Lead
Aimie Rendle
Senior Content Lead
Narges Grau
Senior Content Lead
Matthew Nicolas
Senior Content Lead
Arianna Shahkarami
Account Manager
Our Clients
We’re proud to work with a wide range of internationally recognised organisations across the spectrum of healthcare.
Our Latest Insights
To understand the place of Delphi panels and of other consensus studies, and to stay informed with best practices in 2025, you can read our blog posts. Alongside our whitepapers, they offer insights into evidence and consensus development such as Delphi panels and their applications to healthcare. Take a look at some of our published work that has already helped move decision-making in healthcare forward.
How to Measure the Impact of a Delphi Study
How to Measure the Impact of a Delphi Study In short, the impact of a Delphi study is the change it enables. This may include influencing clinical practice, informing guidelines, shaping research...
Delphi Panel Size: How Many Experts Should Be on a Delphi Panel?
Delphi Panel Size: How Many Experts Should Be on a Delphi Panel? One of the most common questions when planning a Delphi study is: “How many experts do we need on the panel?” Determining...
Practical Delphi Applications for Academic Researchers
Practical Delphi Applications for Academic Researchers Healthcare research is increasingly being conducted in areas where evidence is limited, clinical practice varies, or innovation is evolving faster than formal guidance. In these situations,...
How to Map Evidence Gaps to Support a Successful Launch
How to Map Evidence Gaps to Support a Successful Launch For Medical Affairs, generating clinical data alone is rarely enough to ensure the successful adoption of a therapy. Randomised clinical trials...
Designing Global Delphi Panels to Deliver Actionable Insights
Designing Global Delphi Panels to Deliver Actionable Insights Pharmaceutical companies, medical affairs teams, and guideline developers frequently require global or multi-regional consensus to: Inform global clinical guidelines and align recommendations across...
FAQ
What does Triducive specialise in?
Which industries and organisations does Triducive work with?
Triducive work with commercial (life-sciences), public (medical societies, governmental bodies) and charitable/NGO organisations.
What makes expert consensus more robust than traditional opinion-gathering?
Expert consensus via structured methods like Delphi is more robust because it uses iterative rounds with feedback, anonymity (reducing bias), and systematic refinement of opinions to arrive at aligned, evidence-based statements. This is contrasted with informal surveys or unstructured focus groups, which may lack rigour and stakeholder diversity.
How does consensus research differ from traditional market research or surveys?
Consensus research is methodologically structured, uses iterative rounds, controls feedback, targets expert rather than general respondent panels, and aims for aligned statements or standards. Traditional market research and surveys often collect snapshot opinions, may not iterate or refine, and may not focus on reaching stakeholders’ aligned positions in a domain of professional practice.
How do you ensure that minority voices or less-represented stakeholder groups are heard in the consensus process?
Inclusivity is built into Triducive’s methodology. Panels are designed to represent a balance of perspectives: clinical specialties, geographies, experience levels and professional roles. Anonymity within the Delphi process ensures all voices are weighted equally, preventing dominance by more vocal participants and allowing minority or emerging viewpoints to contribute meaningfully to the final consensus.
What kinds of healthcare challenges are best suited to a Delphi consensus study?
A Delphi consensus study is most valuable where evidence is limited, fragmented or rapidly evolving. It is ideal for defining best practice in areas lacking strong clinical data, prioritising research needs, aligning diverse expert views, developing guidelines or frameworks, and informing policy or service design. Triducive often apply this approach in therapeutic areas with emerging treatments, complex pathways or multi-stakeholder decision-making.
How are results of consensus studies communicated and implemented in clinical practice or policy?
Triducive support clients beyond publication by developing clear communication and advocacy strategies that turn consensus outcomes into practical change. This may include conference presentations, stakeholder briefings, infographics and digital campaigns, all designed to help decision-makers, clinicians and policymakers apply consensus findings in real-world settings.
Can Triducive tailor a consensus study for non-clinical stakeholder groups (e.g., payers, patients, health technology assessment bodies)?
Yes. Triducive frequently tailors Delphi-based studies for non-clinical stakeholders such as payers, policymakers, patient advocates. These studies focus on aligning perspectives across the full healthcare ecosystem, not just among clinicians, ensuring that resulting consensus recommendations are relevant, actionable and sensitive to system-level realities.
Can Triducive support global or cross-country collaborations?
Yes, Triducive work globally, engaging national, regional and international organisations, and across multiple geographies.